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Available online ▪ ▪ ▪AbstractObjective: The aim of this study was to assess the CT findings of chest lesions in patients with systemic lupus erythematosus (SLE), and to
explore its correlation with the age and serum markers (anti-dsDNA antibodies, anti-Sm antibodies, CRP, ESR, C3, C4 and IgG), in an attempt to
speculate the possible mechanism of chest lesions in SLE patients.
Materials and methods: Thirty nine patients who met the SLE classification criteria were enrolled into this study. All patients underwent
serological tests and chest CT examination. The chest CT findings of each patients were analyzed, and its correlation with the age, serum
markers were explored. All data were analyzed by using SPSS 19.0 software. Two-sample t-test was used to analyze the age difference between
the two groups with or without chest lesions. Relationship between the serum markers and the chest lesions was analyzed by using the Fisher's
exact probability method.
Results: All the 39 patients (34 females and 5 males), aged from 19 to 74 years old, the mean age was 44.13 ± 12.17 years old. Among the serum
markers, the positive rate of C3 was the highest (79.49%), ESR positive in 22 patients (56.41%), 9 patients of CRP positive (23.08%). Of all the
39 patients, abnormal manifestations of chest CT were found in 29 patients (74.36%), the most common changes were pulmonary interstitial
changes (66.67%), the second were mediastinal/pleural changes (61.54%), then were the pulmonary parenchymal changes (25.64%) and pul-
monary vascular changes (12.82%). ESR positive rate difference was found between the two groups with or without pulmonary parenchymal
lesions (P < 0.05), and CRP positive rate difference was found between the two groups with or without mediastinal/pleural lesions (P < 0.05).
Conclusion: Chest involvement occurred with high frequency in SLE patients, and the CT manifestations were complex and various, pulmonary
interstitial lesions were the most common. Patients with ESR positive were more susceptible to have pulmonary parenchymal lesions, and
mediastinal/pleural lesions were more common in patients with CRP positive.
© 2016 Beijing You’an Hospital affiliated to Capital Medical University. Production and hosting by Elsevier B.V. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Systemic lupus erythematosus (SLE) is an autoimmune
connective tissue disease, which can affect the skin, joints,
kidneys, lungs, nervous system and other organs of the body.* Corresponding author.
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the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Up to now, the exact cause and pathogenesis of this disease
remain unclear, which are generally accepted as the results of
various factors. It is more common in young and middle-aged
women, and its clinical manifestations are complex and
diverse, mainly including: malar rash, discoid rash, photo-
sensitivity, oral ulcers, arthritis, serositis, renal disorder,
neurological disorder and so on. At present, the diagnosis of
SLE is based on the SLE classification criteria revised by the
American Rheumatism Association in 1997. Due to chest is
rich in connective tissue, more than half of SLE patients haverythematosus and its correlation with serum markers, Radiology of Infectious
. Production and hosting by Elsevier B.V. This is an open access article under
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disease [1], mainly involving pleura, pulmonary interstitium,
pulmonary parenchyma and respiratory muscles [2]. However,
chest CT findings in SLE are complex and variable, they are
also lack of relative specificity, so further research is needed.
As far as we know, about the research of chest CT findings in
SLE patients, there were a large number of literature reports
both at home and abroad. However, in the course of SLE, how
the relationship between the age of patients and the chest le-
sions, and how the correlation between the serum markers of
patients and the chest lesions, were less reported in the liter-
ature. Based on the above background, the aim of this study
was to assess chest CT findings in SLE patients, and to explore
the correlation between the chest CT findings and the age,
serum markers of the patients, through a retrospective analysis
of the chest CT findings and clinical data of 39 SLE patients,
in an attempt to speculate the possible mechanism of chest
lesions in SLE patients.
2. Materials and methods2.1. Clinical dataTable 1
Chest CT findings of all the 39 patients.
Chest CT findings Cases Proportion (%)
Pulmonary parenchymal changes 10 25.64
Consolidation 4 10.26
Patchy infiltration 9 23.08This paper collected 39 SLE patients in the Department of
Rheumatism Immunity of the First Affiliated Hospital of
Nanchang University from March 2015 to October 2015, they
were all confirmed by clinic and met the SLE classification
criteria revised by the American Rheumatism Association in
1997. All the patients underwent serological tests and chest
CT examination. Of all the 39 patients (34 females and 5
males), aged from 19 to 74 years old, the mean age was
44.13 ± 12.17 years old. The clinical course was from several
days to several years. Some patients had a certain symptoms of
chest, mainly including: fever, chest tightness, chest pain,
shortness of breath, the area before the heart discomfort,
cough and dyspnea. Antibiotics had no effect on the chest
symptoms, but cortical hormone therapy had a good effect.
Meanwhile, excluding the chest lesions caused by bacteria,
fungi, tuberculosis, heart failure and so on. Serological tests
were performed in all patients, the serum markers included
anti-dsDNA antibodies, anti-Sm antibodies, CRP, ESR, C3, C4
and IgG.Pulmonary interstitial changes 26 66.67
Ground-glass opacity 12 30.772.2. Chest CT examination
Honeycomb opacity 2 5.13
Funicular opacity 20 51.28
Subpleural line 9 23.08
Interlobular septal thickening 7 17.95
Emphysema 1 2.56
Bronchiectasis 4 10.26
Pulmonary vascular changes 5 12.82
Pulmonary artery trunk broadening 4 10.26
Mosaic sign 3 7.69
Mediastinal/pleural changes 24 61.54
Pleural thickening 8 20.51
Pleural effusion 11 28.21
Pericardial effusion 12 30.77
Podoid enlarging 10 25.64
Mediastinal lymphadenectasis 4 10.26All the patients were examined by using the Toshiba
Aquilion 64 slice CT. Patients were asked to take a deep
breathe and routine chest scan was performed at the end of
the deep inspiration, scan ranged from the thoracic inlet to the
diaphragm, the exposure conditions: tube voltage ¼ 120 kv,
tube current ¼ 100 mA, slice thickness ¼ 5 mm, layer
spacing ¼ 5 mm, matrix ¼ 512  512, then the thin-section
scan of 1 mm and post-processing reconstruction were
performed. CT images of all the patients were observed
and diagnosed by two experienced radiologists respec-
tively, combined with the lung window (window width:
1600e2000HU, window level: 600 ~ 800HU) andPlease cite this article in press as: Li P, et al., Chest CT findings in systemic lupus e
Diseases (2016), http://dx.doi.org/10.1016/j.jrid.2016.08.002mediastinal window (window width: 250e350HU, window
level: 30e50HU).2.3. Statistical analysisAll data were analyzed by using the statistical software
(IBM SPSS 19.0). The age of the patients accorded with
normal distribution, so two-sample t-test was used to analyze
the age difference between the two groups with or without
chest lesions. The relationship between the serum markers
(anti-dsDNA antibodies, anti-Sm antibody, CRP, ESR, C3, C4,
IgG) and the chest lesions was analyzed by using the Fisher's
exact probability method, because the number of patients was
less than forty. A p-value less than 0.05 was considered sta-
tistically significant.
3. Results3.1. Chest CT findingsOf all the 39 patients, abnormal manifestations of chest CT
were found in 29 patients (74.36%), the most common
changes were pulmonary interstitial changes (66.67%), the
second were mediastinal/pleural changes (61.54%), then were
the pulmonary parenchymal changes (25.64%) and pulmonary
vascular changes (12.82%). The proportion of the chest
changes was shown in Table 1, and the abnormal manifesta-
tions of chest CT were shown in Figs. 1e4.3.2. Serum markersAmong the serum markers, the positive rate of C3 was the
highest (79.49%), ESR positive in 22 patients (56.41%), 9
patients of CRP positive (23.08%), as shown in Table 2.rythematosus and its correlation with serum markers, Radiology of Infectious
Fig. 1. Pulmonary interstitial lesions. A: Ground-glass opacity; B: Funicular opacity; C: Honeycomb opacity; D: Reticular opacity; E: Subpleural line; F:
Interlobular septal thickening; G: Emphysema; H: Bronchiectasis.
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chest lesionsAll the 39 patients (34 females and 5 males), aged from 19
to 74 years old, the mean age was 44.13 ± 12.17 years old.
Table 3 was a test of the age difference between the two
groups with or without chest lesions (pulmonary parenchymal/
interstitial/vascular and mediastinal/pleural changes). From
the table, we knew that there was no statistical significance of
the age difference between the two groups with or without
chest lesions (P > 0.05).Please cite this article in press as: Li P, et al., Chest CT findings in systemic lupus e
Diseases (2016), http://dx.doi.org/10.1016/j.jrid.2016.08.0023.4. Correlation between the serum markers of patients
and the chest lesionsTables 4e7 were tests of the positive rate difference of
serum markers (anti-dsDNA antibodies, anti-Sm antibodies,
CRP, ESR, C3, C4, IgG) between the two groups with or
without chest lesions (pulmonary parenchymal/interstitial/
vascular and mediastinal/pleural changes). From the tables,
we found that there was positive rate difference of ESR be-
tween the two groups with or without pulmonary paren-
chymal changes (P ¼ 0.002), and there was positive raterythematosus and its correlation with serum markers, Radiology of Infectious
Fig. 2. Mediastinal/pleural lesions. A: Pericardia/Pleural effusion; B: Mediastinal lymphadenectasis.
Fig. 3. Pulmonary parenchymal lesions. A: Consolidation; B: Patchy infiltration.
Fig. 4. Pulmonary vascular lesions. A: Mosaic sign; B: Pulmonary artery main trunk broadening.
Table 2
Serum markers of all the 39 patients.
Serum markers Positive cases Constituent ratio (%)
Anti-dsDNA antibodies 13 33.33
Anti-Sm antibodies 13 33.33
CRP 9 23.08
ESR 22 56.41
C3 31 79.49
C4 26 66.67
IgG 26 66.67
Table 3
Test of the age difference between the two groups with or without chest
lesions.
Chest CT findings Yes No T value P value
Pulmonary parenchymal
changes
45.30 ± 11.898 43.72 ± 12.438 0.349 0.729
Pulmonary interstitial
changes
45.35 ± 12.608 41.69 ± 11.309 0.882 0.384
Pulmonary vascular
changes
50.80 ± 14.025 43.15 ± 11.784 1.326 0.193
Mediastinal/pleural
changes
45.29 ± 13.434 42.27 ± 9.960 0.751 0.457
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mediastinal/pleural changes (P ¼ 0.007), but there was no
statistical significance of the positive rate difference of serum
markers between the two groups with or without other chest
changes.Please cite this article in press as: Li P, et al., Chest CT findings in systemic lupus e
Diseases (2016), http://dx.doi.org/10.1016/j.jrid.2016.08.0024. Discussion
SLE is an autoimmune connective tissue disease that
various factors are involved in. It often affects multiple organsrythematosus and its correlation with serum markers, Radiology of Infectious
Table 4
Test of the positive rate difference of serum markers between the two groups with or without pulmonary parenchymal changes.
Pulmonary parenchymal changes Anti-dsDNA antibodies Anti-Sm antibodies CRP ESR C3 C4 IgG
þ e þ e þ e þ e þ e þ e þ e
Positive 5 5 4 6 4 6 10 0 9 1 6 4 7 3
Negative 8 21 9 20 5 24 12 17 22 7 20 9 19 10
P value 0.253 0.704 0.197 0.002 0.653 0.704 1.000
Table 5
Test of the positive rate difference of serum markers between the two groups with or without pulmonary interstitial changes.
Pulmonary interstitial changes Anti-dsDNA antibodies Anti-Sm antibodies CRP ESR C3 C4 IgG
þ e þ e þ e þ e þ e þ e þ e
Positive 10 16 10 16 7 19 17 9 19 7 18 8 19 7
Negative 3 10 3 10 2 11 5 8 12 1 8 5 7 6
P value 0.477 0.477 0.689 0.172 0.229 0.725 0.290
Table 6
Test of the positive rate difference of serum markers between the two groups with or without pulmonary vascular changes.
Pulmonary vascular changes Anti-dsDNA antibodies Anti-Sm antibodies CRP ESR C3 C4 IgG
þ e þ e þ e þ e þ e þ e þ e
Positive 2 3 3 2 1 4 2 3 4 1 5 0 4 1
Negative 11 23 10 24 8 26 20 14 27 7 21 13 22 12
P value 1.000 0.310 1.000 0.636 1.000 0.149 0.648
Table 7
Test of the positive rate difference of serum markers between the two groups with or without mediastinal pleural changes.
Mediastinal pleural changes Anti-dsDNA antibodies Anti-Sm antibodies CRP ESR C3 C4 IgG
þ e þ e þ e þ e þ e þ e þ e
Positive 10 14 8 16 9 15 16 8 19 5 17 7 16 8
Negative 3 12 5 10 0 15 6 9 12 3 9 6 10 5
P value 0.295 1.000 0.007 0.184 1.000 0.508 1.000
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positive can be found from the laboratory examination. The
pathological basis of it are vasculitis and perivascular
inflammation caused by immune complex deposition. Because
lung is rich in collagen and blood vessels, lung damage can be
usually found in SLE patients [3], mainly in: pulmonary
interstitium, mediastinum/pleura, pulmonary parenchyma, and
pulmonary vessel. In Clinic, the diagnosis of SLE mainly
depends on clinical symptoms and combines detection of
multiple autoantibodies, but it was rarely associated with chest
changes. However, chest lesions can appear in any stage of the
disease, and it closely related to the living quality of patients.
In this paper, we studied the correlation between the chest CT
findings and the serum markers of SLE patients, then specu-
lated the possible mechanism of chest lesions in SLE patients,
in the hope to guide the clinical diagnosis and treatment.4.1. Chest CTCompared with other connective tissue diseases, chest
involvement in SLE are more common, but its incidence of
each report is quite different, ranging from 7% to 100% [4,5]. In
the past, the diagnosis of chest involvement in SLE mainly
relied on chest X-ray, but it is difficult to find abnormities whilePlease cite this article in press as: Li P, et al., Chest CT findings in systemic lupus e
Diseases (2016), http://dx.doi.org/10.1016/j.jrid.2016.08.002patients with slight chest lesions, especially in the early stage of
some lesions. However, high-resolution computed tomography
(HRCT) can find smaller lesions of lung and pleura with high
sensitivity, it shows the incomparable superiority especially in
the diagnosis of the early and mild disease that common X-ray
cannot find [6]. Now it has been widely used in diagnosing
chest lesions instead of the chest X-ray. The chest lesions of
SLE patients mainly involve the pulmonary interstitium, the
pleura, the pulmonary parenchyma and the respiratory muscle.
Lung volume shrinking is relatively rare, but it is the charac-
teristic expression caused by the damage of diaphragmatic
muscle function [7]. In this study, we found that chest lesions in
SLE patients were common, the most common lesions were
pulmonary interstitial lesions, then they were the mediastinal/
pleural lesions. However, Diane L [8] discovered that the most
common changes were pleurisy or pleural effusion, followed by
pulmonary interstitial and pulmonary parenchymal lesions.4.2. Pulmonary interstitial lesionsThe basic pathological characteristics of pulmonary inter-
stitial lesions are the extensive destruction of alveolar walls,
the loss of functional capillaries and the formation of fibrous
scar. The pathogenesis may be due to the immune complexrythematosus and its correlation with serum markers, Radiology of Infectious
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phages in the lungs to release chemokines and inflammatory
mediators, then leads to inflammatory response, at the same
time stimulates fibroblast proliferation. CT manifestations
mainly include: ground-glass opacity, funicular opacity, hon-
eycomb/reticular opacity, subpleural line, interlobular septal
thickening, emphysema and bronchiectasis. The ground-glass
opacity often suggests that the lesion is reversible in the
early stage of the disease, while reticular and honeycomb
opacities often indicate longer duration of the disease.4.3. Mediastinal/pleural lesionsIn the present study, the incidence of mediastinal/pleural
changes was only inferior to pulmonary interstitial changes. As
we all known, the pathological changes of pleural and pericardial
effusion were mainly infiltration of lymphocytes, monocytes and
plasma cells, sometimes accompanied by small vasculitis and
varying degrees of fibrosis. CT manifestations mainly include:
pericardia/pleural effusion, pleural thickening, mediastinal lym-
phadenectasis. In this study, we found that medium or small
amount of pleural effusion was common in SLE patients, a large
amount of pleural effusion was rare. The pleural effusion could
be on one side or both. When the pleural effusion was on both
sides, it would be distributed evenly on both sides of the thorax.4.4. Pulmonary parenchymal lesionsThe pathological manifestations of pulmonary parenchymal
lesions are not specific, mainly manifest destruction and ne-
crosis of the alveolar structure, infiltration/hemorrhage/edema
of inflammatory cells, and formation of the transparent film.
The main CT findings are consolidation and patchy infiltra-
tion, mostly on both sides, also on one side, the bottom and
periphery of the lung are more obvious. The image cannot be
identified with other pulmonary infections.4.5. Pulmonary vascular lesionsPulmonary vascular lesions are mainly manifested as pul-
monary arteria hypertension. Pulmonary arteria hypertension
is mainly caused by small vasculitis, small pulmonary arteria
embolism and plexal changes of small pulmonary artery. The
main CT findings are mosaic sign and pulmonary artery main
trunk broadening. SLE patients with pulmonary arteria hy-
pertension suggest that the prognosis is not good, the survival
rate of 2 years is less than 50%, Cardiac Ultrasonic exami-
nation can be used as a noninvasive screening [9].4.6. Relationship between the age of patients and the
chest lesionsAbout the research of relationship between the age of pa-
tients and the chest lesions in SLE patients, there were few
literature reports both at home and abroad. Of all the 39 pa-
tients in this study, 34 females and 5 males, ranged from 19 to
74 years old, the average age was 44.13 ± 12.17 years old. WePlease cite this article in press as: Li P, et al., Chest CT findings in systemic lupus e
Diseases (2016), http://dx.doi.org/10.1016/j.jrid.2016.08.002found that there was no relationship between the age of pa-
tients and the chest lesions (pulmonary interstitial, medias-
tinal/pleural, pulmonary parenchymal and pulmonary vascular
lesions) in this study.4.7. Correlation between the autoantibodies and the
chest lesionsAs an autoimmune connective tissue disease, the serum of
SLE patients contains a variety of autoantibodies.
Anti-dsDNA antibody is the marked antibody of SLE, it
almost exists in the serum of all SLE patients and its speci-
ficity is strong. High titer of anti-dsDNA antibody is an
important basis for the diagnosis of SLE, and it is also the sign
of disease activity; Anti-Sm antibody is the anamnestic anti-
body of SLE, the positive rate of it is lower, but the specificity
of it is extremely high, almost up to 100%, so it is often known
as the specific antibody of SLE, but it has nothing to do with
the disease activity. In this study, we found that both the anti-
dsDNA antibody with close relationship to the disease activity
and the anti-Sm antibody of extremely high specificity had no
correlation with the chest lesions (pulmonary interstitial,
mediastinal/pleural, pulmonary parenchymal and pulmonary
vascular lesions). It suggests that the chest lesions of SLE have
a more complex pathogenesis and need further research.4.8. Correlation between the inflammatory indicator and
the chest lesionsCRP is one of the acute phase proteins, which can be used
as the antimicrobial molecule and the marker of inflammation.
Most scholars believe that SLE patients have low levels of
CRP because of the presence of CRP antibody, but the level of
CRP can increase when the patients have serosal effusion
[10,11]. In this study, we found that CRP was associated with
mediastinal/pleural lesions, patients of CRP positive were
more likely to have mediastinal/pleural lesions, which were
mainly manifested as pleural/pericardial effusion, this was
consistent with other studies. At the same time, pleural/peri-
cardial effusion is the active performance of SLE, whether we
could speculate that the level of CRP was related to the disease
activity of SLE? However, the foreign literature has reported
that there was no correlation between the level of CRP and the
disease activity of SLE, but the specific mechanisms still need
further research [12], so this speculation has yet to be further
studied.
ESR is also a common indicator of inflammation in clinic,
its rise usually prompt that the body is in a state of inflam-
mation. In this study, we found that ESR was associated with
pulmonary parenchymal lesions, patients of ESR positive were
prone to have pulmonary parenchymal lesions. But due to the
specificity of ESR is poorer, it can also rise in SLE patients
with anemia, infection, disease activity and organ damage, and
the number of patients in this study was relatively small, the
credibility of the conclusion needs to be improved.
In addition, we also discovered that there was no clear
correlation between C3, C4, IgG and the chest lesions.rythematosus and its correlation with serum markers, Radiology of Infectious
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In summary, it was very common to find chest involvement
in SLE patients. Currently, HRCT is the best imaging tech-
nology in diagnosing the chest lesions in SLE patients. Of all
the patients in this study, chest lesions occurred with high
frequency, and the CT manifestations were complex and
various, pulmonary interstitial changes were the most com-
mon. We can draw preliminary conclusions that pulmonary
parenchymal changes were more common in patients with
ESR positive, and mediastinal/pleural changes more likely
occurred in patients with CRP positive. Nevertheless, the
number of patients in this study was relatively small, and all of
them were inpatients for a period of time, so it could lead to
the inaccurate results. In addition, this study did not group the
patients into active and stable stage. These problems need for
improving in future research.
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